Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Knight Therapeutics
Notice of Knight Therapeutics’ Fourth Quarter and Year End 2025 Results Conference Call
May 1, 2026
Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results
March 19, 2026
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
March 11, 2026
←
Previous Page
1
2